Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2010 Financial Results
Date:2/24/2011

7611,817Contingent consideration expense

858-1,390-Goodwill impairment

---65,099Impairment loss

-3,424-3,424Gain on long-term debt repurchase

---(9,079)Tax effect of the above

(4,663)(5,623)(19,089)(18,934)Non-GAAP adjusted net income

$ 45,618$ 20,808$ 156,855$  83,637Use of Non-GAAP Financial MeasuresOur "non-GAAP adjusted net income" excludes the following items from GAAP net income (loss):

1.  Non-GAAP adjusted net income excludes certain non-cash interest expense resulting from the change in the method of accounting for our convertible notes which became effective in 2009.  We believe that excluding the non-cash portion of our interest expense allows management and investors an alternative view of our financial results "as if" our net income reflected only the cash portion of our interest expense.  

2.  Purchase accounting and product acquisition related adjustments:  Non-GAAP adjusted net income excludes certain items related to our acquisitions. The excluded items include charges related to amortization and step up in inventory related to purchase accounting arising from acquisitions and changes in the fair value of future contingent consideration related to our acquisition of Auralis Limited.

3.  Stock option expense: Non-GAAP adjusted net income excludes the impact of our stock compensation expense. We believe that excluding the impact of expensing stock options better reflects the recurring economic characteristics of our business.

4. Other items: Non-GAAP net income excludes other unusual or non-recurring items that are evaluated on an individual basis. Our eva
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. ViroPharma to Present at Three September Healthcare Conferences
2. ViroPharma to Present at Three October Healthcare Conferences
3. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
4. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
5. ViroPharma to Present at Three November Healthcare Conferences
6. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
7. ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes
8. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
9. ViroPharma Incorporated Reports First Quarter 2009 Financial Results
10. ViroPharma Incorporated Honored by the National Organization for Rare Disorders
11. ViroPharma to Present at Two June Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014  Lisa Kulik saw fireworks for the ... holiday, thanks to a groundbreaking retinal implant co-invented by ... clinician-researcher at the University of Southern California (USC) Eye ... Peoria, Ariz. resident who has retinitis pigmentosa, ... sight. On June 2, she became the first person ...
(Date:8/27/2014)... , Aug. 27, 2014 Guggenheim Securities, the ... today announced the hiring of veteran equity analyst Charles ... analyst. Mr. Butler will focus on the biotech/biopharma sector. ... a wealth of experience and a broad network of ... Senior Managing Director and Head of Equities at Guggenheim ...
(Date:8/27/2014)... , Aug. 27, 2014 Research ... "Global Enzyme for Pulp & Paper Industry Report ... The Global Enzyme for Pulp & Paper Industry Report ... current state of the global enzyme for pulp & ... overview of the industry including definitions, classifications, applications and ...
(Date:8/27/2014)... , Aug. 27, 2014 Tris Pharma, ... delivery technologies, today announced that it has been selected ... & Industry Association,s 2014 Awards for Excellence ... by an independent panel of judges from SCORE (Counselors ... Award winners will be honored at a gala event ...
Breaking Biology Technology:USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 2USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 3USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 4USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 5Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Global Enzyme for Pulp & Paper Industry Report 2014 2Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2
... Pharmaceuticals, Inc. (NYSE Amex: AEN ), a developer ... today that James S. Kuo, M.D., M.B.A., the Company,s Chief ... its Alzheimer,s program at the NYC Medtech Forum. Adeona will ... on Tuesday evening, October 11, 2011, at the offices of ...
... Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), ... discovery, development, manufacture and sale of enzyme ... enzyme and biopharmaceutical industries, today announced that ... $3,000,000 in convertible subordinated secured promissory notes ...
... 5, 2011 Elsevier, a world-leading provider ... and the University of Sydney, Australia,s leading higher education ... 24-hour Sydney Hackathon . From ... software applications to improve delivery of scientific, medical and ...
Cached Biology Technology:Adeona CEO to Present at the NYC Medtech Forum 2Elsevier and the University of Sydney Announce Prize Winners of 24-Hour Hackathon 2Elsevier and the University of Sydney Announce Prize Winners of 24-Hour Hackathon 3Elsevier and the University of Sydney Announce Prize Winners of 24-Hour Hackathon 4Elsevier and the University of Sydney Announce Prize Winners of 24-Hour Hackathon 5
(Date:8/27/2014)... are often depicted as giant, frightening beasts. But every ... of a rock slab containing fossils of 24 very ... a group of hatchlings overseen by a caretaker, according ... , Penn,s Brandon P. Hedrick and Peter Dodson led ... of Natural History, where the specimen is held. Hedrick ...
(Date:8/27/2014)... New York, NY (June, 2014) Outstanding basic ... treatments, and a dedication to patient care have ... of Columbia University Medical Center (CUMC) and NewYork-Presbyterian ... Grant from the National Cancer Institute (NCI). The ... only two NCI-designated Comprehensive Cancer Centers in New ...
(Date:8/27/2014)... University of Adelaide research has shown that piglets can ... birthing frequency. , The outcome of the study at ... Animal Reproduction Science , is an important finding for ... welfare without loss of production. , "Sows don,t usually ... on heat after their piglets have been weaned," says ...
Breaking Biology News(10 mins):Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 2Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4Piglet weaning age no bar to litter frequency 2
... , Technological advancements in medicine have allowed patients suffering ... to regain mobility and live relatively pain-free. But some ... the U.S. Food and Drug Administration (FDA) are not ... is tested to determine its safety and effectiveness. ...
... , Muscular dystrophy is caused by the largest human gene, ... Research conducted at the University of Missouri and described this ... of Sciences has identified significant sections of ... and families. , MU scientists Dongsheng Duan, PhD, and Yi ...
... German . Trees do not grow in ... into oases for deep-sea life - at least temporarily until ... researchers from Germany now showed how sunken wood can develop ... By using underwater robot technology, they confirmed their hypothesis that ...
Cached Biology News:A call to prevent unsafe high-risk medical devices from reaching the marketplace 2A call to prevent unsafe high-risk medical devices from reaching the marketplace 3Scientists discover 'needle in a haystack' for muscular dystrophy patients 2Scientists discover 'needle in a haystack' for muscular dystrophy patients 3Wood on the seafloor -- an oasis for deep-sea life 2
Large-capacity refrigerated incubator chamber holds up to 4 independently-operated shakers. Programmable heat, refrigeration, humidifcation are standard. Photosynthetic operation, optional....
... Ligands\n\nReceptor-related research has long been enabled by ... selected to keep pace with new discoveries. ... and services for receptor research and drug ... you do not find exactly what you ...
Denhardt's powder mixture (for 50X stock solution)...
... system and disposable ESI Chip allow users ... of electrospray mass spectrometers for life science ... users to either speed analysis for increased ... applications, or long acquisition times for proteomics ...
Biology Products: